HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Vyaire Medical Issues Voluntary Correction for Certain bellavista Ventilators in Specific Software Configurations

There is a potential issue with bellavista™ 1000 and 1000e ventilators that have software version 6.0.1600.0 or higher installed, which was deployed in February 2021, and also have the Data Communication port set to "HL7".

Dexcom G6 Continuous Glucose Monitoring System – Now Covered in Alberta for Children and Youth Living With Diabetes

Dexcom G6 Continuous Glucose Monitoring System Dexcom announced today that people with diabetes who are under 18 years old and require ongoing use of insulin...

Vivalink Survey Shows that 68 Percent of Clinicians Find MCT Offers Better Detection and Diagnosis than Traditional Holter Monitors

The survey asked 100 U.S. clinicians, including cardiologists, electrophysiologists, nurse practitioners and physician assistants if the Holter monitor, invented in the 1950s, still meets the needs of patients and providers.

LUNGGuard® Used in Record Cross-Country Donor Lung Transplant Case Reports Paragonix Technologies

Both the Paragonix LUNGGuard System and the SherpaPak Cardiac Transportation System (CTS) provide a sterile and temperature-controlled environment for organs traveling between operating rooms and serve as an alternative to traditional ice transportation.

Empirical Spine Advances LimiFlex™ As a New Motion-Preserving, Minimally Invasive Standard in Spine Surgery

LimiFlex is an investigational device targeting grade 1 lumbar degenerative spondylolisthesis patients with spinal stenosis, designed to restore natural segmental motion and stability after an open lumbar decompression by augmenting the posterior tension band.

Spatz3 Adjustable Balloon Delivers the Highest Weight Loss Results

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Prof Barham K Abu Dayyeh MD et al. The Lancet. Volume 398, Issue 10315, 27 November–3 December 2021, Pages 1965-1973.  

Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $214 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals

The summary distribution agreement will be followed by a more comprehensive agreement. The agreement with Glo-Med follows the distribution agreements signed in the last quarter of 2021 targeting approximately $174 million in Europe (Spain, Portugal, Poland, Czech Republic and Slovakia) subject to regulatory approvals.

WellSky to Deliver In-Home Protocols for Patients With Heart Failure

Dr. Brent Lampert and Dr. Raymond Benza will lead the program at Ohio State Wexner Medical Center.

Medline Unveils New CLABSI Prevention Solution

The need for standardization in the vascular access health space is significant, especially with CLABSI incidents rapidly increasing since the onset of the pandemic. According to the Centers of Disease Control and Prevention (CDC), CLABSIs have increased about 24% since the onset of the pandemic.